Su Judy Y, Vo Anhkiet C
Department of Anesthesiology, University of Washington, Seattle, 98195-6540, USA.
Anesthesiology. 2002 Jan;96(1):155-61. doi: 10.1097/00000542-200201000-00029.
Activation or inhibition of protein kinase C (PKC) has been implicated in the anesthetic-induced contraction or relaxation of different types of arteries. In skinned pulmonary arterial strips, the initial halothane-induced contraction has been attributed to PKC activation, but the subsequent relaxation has not. Whether isoflurane has a similar biphasic effect is not known. This study examined the role of PKC and its isoforms in the effect of isoflurane on pulmonary artery.
Rabbit pulmonary arterial strips were mounted on force transducers and treated with saponin to make the sarcolemma permeable ("skinned" strips). Skinned strips were activated by low Ca(2+) (pCa 6.5 or pCa 6.3 buffered with 7 mm EGTA) or the PKC activator phorbol-12,13-dibutyrate (1 microm) until force reached a steady state (control). Various concentrations of isoflurane (test) were administered, and force was observed at time intervals up to 60 min. The PKC inhibitors (bisindolylmaleimide and Go6976 from 0.1 to 10 microm) were preincubated in a relaxing solution and the subsequent contracting solutions. The results were expressed as a percentage of control, with P < 0.05 considered significant for statistical comparison between the tests and time controls.
In a dose-dependent fashion, isoflurane (1-5%) initially increased (5-40%) and then decreased (3-70%) the Ca(2+)- or phorbol-12,13-dibutyrate (pCa 6.7 buffer)-activated force. The increased in force caused by isoflurane was partially reduced by 3 and 10 microm bisindolylmaleimide, but not by Go6976. Isoflurane-induced relaxation was partially prevented by both inhibitors at 0.1 and 0.3 microm.
Isoflurane causes biphasic effects in skinned pulmonary arterial strips that may be in part mediated by different isoforms of PKC.
蛋白激酶C(PKC)的激活或抑制与麻醉药诱导的不同类型动脉的收缩或舒张有关。在去表皮肺动脉条中,最初氟烷诱导的收缩归因于PKC激活,但随后的舒张并非如此。异氟烷是否有类似的双相效应尚不清楚。本研究探讨了PKC及其亚型在异氟烷对肺动脉作用中的作用。
将兔肺动脉条安装在力传感器上,并用皂角苷处理以使肌膜通透(“去表皮”条)。去表皮条通过低钙(用7 mM乙二醇双(2-氨基乙基醚)四乙酸缓冲的pCa 6.5或pCa 6.3)或PKC激活剂佛波醇-12,13-二丁酸酯(1 μM)激活,直至力达到稳态(对照)。给予不同浓度的异氟烷(试验),并在长达60分钟的时间间隔内观察力。PKC抑制剂(双吲哚马来酰亚胺和Go6976,浓度为0.1至10 μM)在松弛溶液和随后的收缩溶液中预孵育。结果以对照的百分比表示,P < 0.05被认为在试验和时间对照之间的统计比较中有显著意义。
异氟烷(1-5%)以剂量依赖方式最初增加(5-40%)然后降低(3-70%)钙或佛波醇-12,13-二丁酸酯(pCa 6.7缓冲液)激活的力。异氟烷引起的力增加被3 μM和10 μM双吲哚马来酰亚胺部分降低,但未被Go6976降低。异氟烷诱导的舒张在0.1 μM和0.3 μM时被两种抑制剂部分阻止。
异氟烷在去表皮肺动脉条中产生双相效应,这可能部分由PKC的不同亚型介导。